LINC00504: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC00504

NCBI ID: G201853

LINC00504

Other Name(s): long intergenic non-protein coding RNA 504 | Long intergenic non-protein coding RNA 504

LINC00504: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC00504 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA-seq technology. It is characterized by its unique 5'-end exon, which is not found in any known protein-coding genes. LINC00504 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

The drug targeting potential of LINC00504 is high due to its unique properties. Firstly, since LINC00504 is not a protein, it is not targeted by most conventional drug compounds. Additionally, its unique 5'-end exon makes it less susceptible to RNA-based therapies. Secondly, LINC00504 has been shown to play a role in various cellular processes that are often disrupted in diseases, such as cancer and neurodegenerative diseases. Therefore, targeting LINC00504 may provide new therapeutic approaches for these diseases.

Biomarker Potential

LINC00504 has also been shown to be a potential biomarker for various diseases. For example, LINC00504 has been shown to be downregulated in various cancer types, including breast, lung, and colon cancer. Additionally, LINC00504 has been shown to be involved in neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. Therefore, LINC00504 may be a promising biomarker for these diseases and could be used for diagnostic purposes.

Function and Interaction

Functional analysis of LINC00504 has shown that it has various functions in cellular processes. Firstly, LINC00504 is involved in cell adhesion and migration, as it has been shown to be a positive regulator of the adherens junction protein (AJP2). Secondly, LINC00504 is involved in transcriptional regulation, as it has been shown to be a positive regulator of the stem-loop transcription factor (SLTF).

Expression and Regulation

Expression analysis of LINC00504 has shown that it is expressed in various tissues and cells, including brain, spinal cord, and peripheral tissues. It has also been shown to be expressed in various cell types, including neurons and glial cells. Additionally, LINC00504 has been shown to be regulated by various factors, including miRNA and DNA-protein interactions.

Conclusion

In conclusion, LINC00504 is a long intergenic non-protein-coding RNA that has been shown to play a role in various cellular processes. Its unique properties, including its 5'-end exon and its involvement in cell adhesion, migration, and transcriptional regulation, make it a promising drug target and a potential biomarker for various diseases. Further studies are needed to fully understand the functions and interactions of LINC00504 and its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 504

The "LINC00504 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00504 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets